Profile
Peder Møller Andersen currently works at Biosergen AB, as Chief Medical Officer from 2024.
Dr. Andersen also formerly worked at Biosergen AS, as Chief Executive Officer & Director, Forward Pharma GmbH, as Managing Director from 2009 to 2016, Astion Pharma A, as Vice President-Clinical Development from 2010 to 2012, and Forward Pharma A, as Chief Operating Officer in 2017.
Dr. Andersen received his doctorate degree in 1981 from the University of Copenhagen.
Peder Andersen active positions
| Companies | Position | Start |
|---|---|---|
| BIOSERGEN AB | Chief Tech/Sci/R&D Officer | 2024-01-30 |
Former positions of Peder Andersen
| Companies | Position | End |
|---|---|---|
| FORWARD PHARMA A/S | Chief Executive Officer | 2017-02-28 |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Chief Executive Officer | 2015-12-31 |
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Chief Tech/Sci/R&D Officer | 2011-12-31 |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Chief Executive Officer | - |
Training of Peder Andersen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Astion Pharma A/S
Astion Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Forward Pharma GmbH
Forward Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
Biosergen AB
Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
- Stock Market
- Insiders
- Peder Andersen
















